News Sentiment

FBIOP sentiment intelligence

Fortress Biotech Inc Pref Series A news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 20.06 Week of 19 Jun 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

75/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-3.1% over one week, +20.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Fortress Biotech Inc (FBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 75/100 classification
One-week reaction -3.1% Price reacting lower
Trend fit Trend active 20.1% over four weeks
Fair value 95.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 36
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
newsline.com 6
Market source 6
TradingView 5
TradingKey 4
Stock Traders Daily 4
Seeking Alpha 2
Sahm 2
AD HOC NEWS 2

Event Lens

What the news is about

Classified themes
Earnings 22
Market update 18
Deals and strategy 2
Guidance 2
Balance sheet 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47
TradingView Direct company coverage

Fortress Biotech Inc expected to post a loss of 22 cents a share - Earnings Preview

Fortress Biotech Inc (FBIO) is anticipated to report a loss of 22 cents per share, according to this earnings preview. The article, provided by Refinitiv, gives a brief outlook on the company's upcoming financial results.

Tone
Neutral 50/100
Event
Earnings
Published
09 May 2026 01:09
Source
TradingView
Simply Wall Street Direct company coverage

Fortress Biotech (Nasdaq:FBIO) - Stock Analysis

This Simply Wall St analysis of Fortress Biotech (FBIO) indicates the stock is currently undervalued by analysts, with earnings projected to grow significantly. However, the company faces financial risks including less than a year of cash runway and a small market capitalization.

Tone
Neutral 50/100
Event
Earnings
Published
07 May 2026 13:40
Source
Simply Wall Street